PSEN1 and Alzheimer disease: Although many FAD mutations in APP and PSEN1 have been well-characterized over the past 20 years, the advent of more sophisticated sequencing techniques allows for the identification of an infinite number of genetic changes associated with AD which could not only give insight into disease pathogenesis but also identify novel therapeutic candidates.